JP2011251155A5 - - Google Patents

Download PDF

Info

Publication number
JP2011251155A5
JP2011251155A5 JP2011175996A JP2011175996A JP2011251155A5 JP 2011251155 A5 JP2011251155 A5 JP 2011251155A5 JP 2011175996 A JP2011175996 A JP 2011175996A JP 2011175996 A JP2011175996 A JP 2011175996A JP 2011251155 A5 JP2011251155 A5 JP 2011251155A5
Authority
JP
Japan
Prior art keywords
cardiomyopathy
adverse events
left ventricular
inhalation
dysfunction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011175996A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011251155A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2011251155A publication Critical patent/JP2011251155A/ja
Publication of JP2011251155A5 publication Critical patent/JP2011251155A5/ja
Pending legal-status Critical Current

Links

JP2011175996A 2009-06-30 2011-08-11 肺高血圧の臨床的または超音波心臓検査上の証拠を伴う低酸素性呼吸器不全に罹った満期産およびほぼ満期産の新生児を治療する方法 Pending JP2011251155A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49459809A 2009-06-30 2009-06-30
US12/494,598 2009-06-30

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2010139671A Division JP2011011059A (ja) 2009-06-30 2010-06-18 肺高血圧の臨床的または超音波心臓検査上の証拠を伴う低酸素性呼吸器不全に罹った小児を治療する方法

Publications (2)

Publication Number Publication Date
JP2011251155A JP2011251155A (ja) 2011-12-15
JP2011251155A5 true JP2011251155A5 (https=) 2012-08-16

Family

ID=42062590

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2009157623A Pending JP2011010865A (ja) 2009-06-30 2009-07-02 肺高血圧の臨床的または超音波心臓検査上の証拠を伴う低酸素性呼吸器不全に罹った満期産およびほぼ満期産の新生児を治療する方法
JP2010139671A Withdrawn JP2011011059A (ja) 2009-06-30 2010-06-18 肺高血圧の臨床的または超音波心臓検査上の証拠を伴う低酸素性呼吸器不全に罹った小児を治療する方法
JP2011175996A Pending JP2011251155A (ja) 2009-06-30 2011-08-11 肺高血圧の臨床的または超音波心臓検査上の証拠を伴う低酸素性呼吸器不全に罹った満期産およびほぼ満期産の新生児を治療する方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2009157623A Pending JP2011010865A (ja) 2009-06-30 2009-07-02 肺高血圧の臨床的または超音波心臓検査上の証拠を伴う低酸素性呼吸器不全に罹った満期産およびほぼ満期産の新生児を治療する方法
JP2010139671A Withdrawn JP2011011059A (ja) 2009-06-30 2010-06-18 肺高血圧の臨床的または超音波心臓検査上の証拠を伴う低酸素性呼吸器不全に罹った小児を治療する方法

Country Status (7)

Country Link
US (12) US20100330193A1 (https=)
EP (3) EP2540304A1 (https=)
JP (3) JP2011010865A (https=)
AU (3) AU2009202685B1 (https=)
CA (2) CA3130908A1 (https=)
MX (1) MX2010006055A (https=)
WO (1) WO2011002606A1 (https=)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7523752B2 (en) 2005-09-21 2009-04-28 Ino Therapeutics, Llc System and method of administering a pharmaceutical gas to a patient
AU2009202685B1 (en) 2009-06-30 2010-08-19 Ino Therapeutics Llc Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension
JP2012100240A (ja) 2010-03-09 2012-05-24 Ricoh Co Ltd 画像処理装置、及び、画像処理方法
ES2582309T3 (es) 2010-08-03 2016-09-12 G. Pohl-Boskamp Gmbh & Co. Kg Uso de trinitrato de glicerilo para el tratamiento de edema traumático
RU2495493C2 (ru) * 2010-10-25 2013-10-10 Государственное образовательное учреждение высшего профессионального образования "Московский государственный университет геодезии и картографии" (МИИГАиК) Способ прогнозирования риска смертности населения в зоне возникновения и нарастания концентрации загрязняющих веществ в атмосферном воздухе
DK2661300T3 (en) 2011-01-06 2018-01-15 Ino Therapeutics Llc Gas supply device and system
WO2012113564A1 (en) 2011-02-25 2012-08-30 G. Pohl-Boskamp Gmbh & Co. Kg Stabilized granules containing glyceryl trinitrate
WO2012122096A2 (en) * 2011-03-04 2012-09-13 Sterling Point Research, Llc Systems and methods for optimizing medical care through data monitoring and feedback treatment
EP2713723B1 (en) * 2011-05-27 2018-09-12 Geno LLC Method of determining vasoreactivity using inhaled nitric oxide
FR2976260B1 (fr) 2011-06-09 2013-07-05 Air Liquide Procede de conditionnement de melanges no/n2 avec etapes de purge et rincage gazeux prealable
FR2976259B1 (fr) * 2011-06-09 2013-07-05 Air Liquide Procede de conditionnement d'un melange gazeux no/n2
FR2976258B1 (fr) * 2011-06-09 2014-09-05 Air Liquide Installation de conditionnement de no a debitmetres massiques
FR2977298B1 (fr) * 2011-06-29 2015-02-06 Air Liquide Bouteille en aluminium pour melange gazeux no/azote
HK1198520A1 (en) 2011-11-07 2015-05-15 Mallinckrodt Hospital Products IP Limited Apparatus and method for monitoring nitric oxide delivery
US10426913B2 (en) 2011-11-07 2019-10-01 Mallinckrodt Hospital Products IP Limited Apparatus and method for monitoring nitric oxide delivery
US20150272988A1 (en) 2012-03-07 2015-10-01 Advanced Inhalation Therapies (Ait) Ltd. Inhalation of nitric oxide for treating respiratory diseases
US8944051B2 (en) 2012-04-05 2015-02-03 Ino Therapeutics Llc Breathing apparatus detection and purging
FR2991026B1 (fr) * 2012-05-24 2014-07-04 Air Liquide Sante Int Conditionnement a haute pression d'un melange gazeux no/azote
FR2991025B1 (fr) * 2012-05-24 2014-07-04 Air Liquide Sante Int Conditionnement d'un melange gazeux no/azote a haute concentration en no
US9248099B2 (en) 2012-05-31 2016-02-02 Desmoid Aktiengesellschaft Use of stabilized granules containing glyceryl trinitrate for arteriogenesis
PL2668947T3 (pl) 2012-05-31 2017-06-30 G. Pohl-Boskamp Gmbh & Co. Kg Indukcja arteriogenezy donorem NO, takim jak nitrogliceryna
US9795756B2 (en) 2012-12-04 2017-10-24 Mallinckrodt Hospital Products IP Limited Cannula for minimizing dilution of dosing during nitric oxide delivery
TR201707036T4 (en) 2012-12-04 2018-11-21 Ino Therapeutics Llc Cannula to minimize dose dilution during administration of nitric oxide
WO2014136111A2 (en) 2013-03-07 2014-09-12 Advanced Inhalation Therapies (Ait) Ltd. Inhalation of nitric oxide for treating respiratory diseases
WO2014160373A1 (en) * 2013-03-13 2014-10-02 Ino Therapeutics Llc Devices and methods for monitoring oxygenation during treatment with delivery of nitric oxide
AU2014227790B2 (en) 2013-03-15 2019-03-14 Mallinckrodt Hospital Products IP Limited Therapeutic gas delivery device with pulsed and continuous flow control
ES2981406T3 (es) 2013-03-15 2024-10-08 Mallinckrodt Pharmaceuticals Ireland Ltd Administración y monitorización de óxido nítrico en fluidos ex vivo
EP2968827B1 (en) 2013-03-15 2019-02-20 The General Hospital Corporation Synthesis of nitric oxide gas for inhalation
MX370385B (es) 2013-03-15 2019-12-11 Massachusetts Gen Hospital Sintesis inspiratoria de oxido nitrico.
US9629358B2 (en) 2013-03-15 2017-04-25 Mallinckrodt Hospital Products IP Limited Administration and monitoring of nitric oxide in ex vivo fluids
US10342948B2 (en) 2013-03-18 2019-07-09 Mallinckrodt Hospital Products IP Limited Therapeutic gas delivery device with pulsed and continuous flow control
WO2014210030A2 (en) * 2013-06-25 2014-12-31 Ino Therapeutics Llc Methods of reducing the risk of mortality associated with a medical treatment
US10512741B2 (en) 2013-09-13 2019-12-24 Mallinckrodt Hospital Products IP Limited Clinical decision support system and methods
EP2878310B1 (en) 2013-11-29 2017-01-11 G. Pohl-Boskamp GmbH & Co. KG Sprayable aqueous composition comprising glyceryl trinitrate
US9381212B2 (en) 2014-01-10 2016-07-05 Mallinckrodt Hospital Products IP Limited Methods of using inhaled nitric oxide gas for treatment of acute respiratory distress syndrome in children
US10188822B2 (en) 2014-03-13 2019-01-29 Mallinckrodt Hospital Products IP Limited Gas delivery device and system for use in magnetic resonance imaging
US10226592B2 (en) 2014-04-01 2019-03-12 Mallinckrodt Hospital Product Ip Limited Systems and method for delivery of therapeutic gas to patients in need thereof using enhanced breathing circuit gas (BCG) flow measurement
US10071213B2 (en) 2014-05-02 2018-09-11 Mallinckrodt Hospital Products IP Limited Systems and method for delivery of therapeutic gas to patients, in need thereof, receiving breathing gas from a ventilator that varies at least pressure and/or flow using enhanced therapeutic gas (NO) flow measurement
WO2015172160A1 (en) 2014-05-09 2015-11-12 Ino Therapeutics Llc Systems and methods for intelligent gas source management and/or systems and methods for delivery of therapeutic gas and/or enhanced performance verification for therapeutic gas delivery
US10384031B1 (en) 2014-06-20 2019-08-20 Mallinckrodt Hospital Products IP Limited Systems and methods for manufacturing and safety of an NO2-to-NO reactor cartridge used to deliver NO for inhalation therapy to a patient
JP6317206B2 (ja) * 2014-07-30 2018-04-25 日本光電工業株式会社 生体情報測定装置、作動方法、及びプログラム
US10758703B2 (en) 2014-10-17 2020-09-01 Mallinckrodt Hospital Products IP Limited Systems and methods for providing a pulse of a therapeutic gas with a desired flow profile to maximize therapeutic effectiveness
ES2822215T3 (es) 2014-10-20 2021-04-29 Massachusetts Gen Hospital Sistemas y métodos de síntesis de óxido nítrico
AU2016243801B2 (en) 2015-04-02 2020-05-21 Hill-Rom Services Pte. Ltd. Manifold for respiratory device
AU2016297622B2 (en) 2015-07-22 2020-06-18 Viaderm Llc Cardiac assist device
MX2018004020A (es) 2015-10-01 2018-09-11 Mallinckrodt Hospital Products Ip Ltd Dispositivo y método para la dispersión de no de concentración alta con gas de terapia de inhalación.
JP7045319B2 (ja) 2016-02-02 2022-03-31 マリンクロット ホスピタル プロダクツ アイピー リミテッド 呼吸ガス流の計測における中断の補償
US10398820B2 (en) * 2016-02-12 2019-09-03 Mallinckrodt Hospital Products IP Limited Use and monitoring of inhaled nitric oxide with left ventricular assist devices
BR112018069582A2 (pt) 2016-03-25 2019-01-22 Massachusetts Gen Hospital sistemas e métodos de entrega para síntese elétrica de plasma de óxido nítrico
WO2018157175A1 (en) 2017-02-27 2018-08-30 Third Pole, Inc. Systems and methods for ambulatory generation of nitric oxide
BR112019016708B1 (pt) 2017-02-27 2024-01-30 Third Pole, Inc Sistemas de geração de óxido nítrico
MX2020010523A (es) 2017-02-27 2021-02-09 Third Pole Inc Sistemas y metodos para generar oxido nitrico.
WO2018183811A1 (en) 2017-03-31 2018-10-04 The General Hospital Corporation Systems and methods for a cooled nitric oxide generator
US20200188319A1 (en) * 2017-08-30 2020-06-18 Bellerophon Pulse Technologies Llc Use Of Inhaled Nitric Oxide For The Treatment Of Pulmonary Hypertension Associated With Lung Disease
US11413445B2 (en) * 2019-03-12 2022-08-16 Heartware, Inc. Method of monitoring health conditions of a patient having an implantable blood pump
WO2020232414A1 (en) 2019-05-15 2020-11-19 Third Pole, Inc. Architectures for production of nitric oxide
CN114269685A (zh) 2019-05-15 2022-04-01 第三极股份有限公司 用于一氧化氮生成的电极
EP3969416A4 (en) 2019-05-15 2023-11-01 Third Pole, Inc. SYSTEMS AND DEVICES FOR GENERATING NITROGEN OXIDE
EP3980373A1 (en) * 2019-06-04 2022-04-13 Thirty Holdings Limited Methods and compositions for generating nitric oxide and uses thereof
EP4069069A4 (en) 2020-01-11 2024-07-03 Third Pole, Inc. SYSTEMS AND METHODS FOR NITROGEN OXIDE PRODUCTION WITH HUMIDITY CONTROL
EP4167920A4 (en) 2020-06-18 2024-06-12 Third Pole, Inc. Systems and methods for preventing and treating infections with nitric oxide
WO2022082072A1 (en) 2020-10-16 2022-04-21 Third Pole, Inc. Nitric oxide generation process controls
EP4405019A4 (en) 2021-09-23 2025-07-16 Third Pole Inc SYSTEMS AND METHODS FOR PROVIDING NITRIC OXIDE
WO2023201363A2 (en) 2022-04-14 2023-10-19 Third Pole, Inc. Delivery of medicinal gas in a liquid medium
USD1087129S1 (en) 2023-02-14 2025-08-05 Mallinckrodt Pharmaceuticals Ireland Limited Display screen or portion thereof with graphical user interface
USD1060405S1 (en) 2023-02-14 2025-02-04 Mallinckrodt Pharmaceuticals Ireland Limited Display screen or portion thereof with graphical user interface
USD1069817S1 (en) 2023-02-14 2025-04-08 Mallinckrodt Pharmaceuticals Ireland Limited Display screen or portion thereof with graphical user interface
USD1064285S1 (en) 2023-02-14 2025-02-25 Mallinckrodt Pharmaceuticals Ireland Limited Therapeutic gas delivery cart
USD1108635S1 (en) 2023-02-14 2026-01-06 Mallinckrodt Pharmaceuticals Ireland Limited Therapeutic gas delivery device
USD1092742S1 (en) 2023-02-14 2025-09-09 Mallinckrodt Pharmaceuticals Ireland Limited Therapeutic gas cylinder bay
USD1092732S1 (en) 2023-02-14 2025-09-09 Mallinckrodt Pharmaceuticals Ireland Limited Injector module
USD1073017S1 (en) 2023-02-14 2025-04-29 Mallinckrodt Pharmaceuticals Ireland Limited Gas cylinder
USD1061594S1 (en) 2023-02-14 2025-02-11 Mallinckrodt Pharmaceuticals Ireland Limited Display screen or portion thereof with graphical user interface
USD1114617S1 (en) 2023-08-15 2026-02-24 Becton, Dickinson And Company Medical device package with surface ornamentation
USD1084322S1 (en) 2023-08-15 2025-07-15 Becton, Dickinson And Company Disinfecting unit label for a medical device
USD1081795S1 (en) 2023-08-15 2025-07-01 Becton, Dickinson And Company Medical device label
USD1114616S1 (en) 2023-08-15 2026-02-24 Becton, Dickinson And Company Medical device package with surface ornamentation
CN117379683B (zh) * 2023-12-12 2024-02-27 苏州晟智医疗科技有限公司 反搏辅助装置、计算设备、存储介质及反搏系统

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5570683A (en) * 1990-12-05 1996-11-05 The General Hospital Corporation Methods and devices for treating pulmonary vasoconstriction and asthma
EP1875917A3 (en) 1990-12-05 2012-11-28 The General Hospital Corporation Use of NO for the treatment or prevention of reversible pulmonary vasoconstriction
FR2695831B1 (fr) 1992-09-24 1994-11-10 Air Liquide Installation et procédé de fourniture d'un mélange gazeux aux voies respiratoires d'un utilisateur.
US5670125A (en) 1993-09-30 1997-09-23 The Boc Group, Inc. Process for the purification of nitric oxide
US5728705A (en) 1993-10-04 1998-03-17 The Trustees Of Columbia University In The City Of New York Method of inducing vasorelaxation to treat pulmonary hypertension
GB9320978D0 (en) 1993-10-12 1993-12-01 Higenbottam Timohy W Nitric oxide treatment
US5558083A (en) 1993-11-22 1996-09-24 Ohmeda Inc. Nitric oxide delivery system
US5514204A (en) 1994-07-07 1996-05-07 The Boc Group, Inc. Process for the purification of nitric oxide
US5417950A (en) 1994-07-07 1995-05-23 The Boc Group, Inc. Process for the purification of nitric oxide
US6063407A (en) 1995-02-16 2000-05-16 The General Hospital Corporation Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
US5670127A (en) 1995-09-26 1997-09-23 The Boc Group, Inc. Process for the manufacture of nitric oxide
US5699790A (en) 1996-03-21 1997-12-23 Ohmeda Inc. System for predicting NO2 concentrations
US5692495A (en) 1996-04-02 1997-12-02 The Boc Group, Inc. Method and apparatus for the production of nitric oxide gas mixture
ES2267141T3 (es) 1996-04-05 2007-03-01 The General Hospital Corporation Tratamiento de una hemoglobinopatia.
US5732694A (en) 1996-12-13 1998-03-31 Ohmeda Inc. System for correcting NO2 monitor
US5732693A (en) 1996-10-02 1998-03-31 Ohmeda Inc. Pause control of nitric oxide therapy
US5752504A (en) 1996-12-13 1998-05-19 Ohmeda Inc. System for monitoring therapy during calibration
US5890490A (en) 1996-11-29 1999-04-06 Aylsworth; Alonzo C. Therapeutic gas flow monitoring system
US6259654B1 (en) 1997-03-28 2001-07-10 Telaric, L.L.C. Multi-vial medication organizer and dispenser
JP2001517108A (ja) 1997-01-17 2001-10-02 メッサー オーストリア ゲゼルシャフト ミット ベシュレンクテル ハフツング 制御されるガス供給システム
US5918596A (en) 1997-04-22 1999-07-06 Instrumentarium Corp. Special gas dose delivery apparatus for respiration equipment
US6125846A (en) 1997-05-16 2000-10-03 Datex-Ohmeda, Inc. Purge system for nitric oxide administration apparatus
US6164276A (en) 1997-05-16 2000-12-26 Datex-Ohmeda, Inc. Accurate dose nitric oxide pulse delivery device with monitoring and alarms
US5846973A (en) 1997-05-23 1998-12-08 Eli Lilly And Company Methods of treating pulmonary hypertension
US6109260A (en) 1998-02-18 2000-08-29 Datex-Ohmeda, Inc. Nitric oxide administration device with timed pulse
US6142147A (en) 1998-03-31 2000-11-07 The General Hospital Corporation Nasal delivery system for inhaled nitric oxide
US6089229A (en) 1998-05-26 2000-07-18 Datex-Ohmeda, Inc. High concentration no pulse delivery device
US7678390B2 (en) 1999-04-01 2010-03-16 Yale University Carbon monoxide as a biomarker and therapeutic agent
US6581599B1 (en) 1999-11-24 2003-06-24 Sensormedics Corporation Method and apparatus for delivery of inhaled nitric oxide to spontaneous-breathing and mechanically-ventilated patients
US6601580B1 (en) 2000-06-28 2003-08-05 The General Hospital Corporation Enhancing therapeutic effectiveness of nitric oxide inhalation
US7114510B2 (en) 2000-11-17 2006-10-03 Ino Therapeutics, Inc. Valve with smart handle
MXPA03012031A (es) 2001-06-21 2005-07-01 Univ Yale El monoxido de carbono mejoraresultados en transplantes de tejido y organo y suprime apoptosis.
EP1429829B1 (en) 2001-09-05 2013-11-27 Geno LLC Nitric oxide generation
BRPI0307673A2 (pt) 2002-02-13 2016-11-08 Beth Israel Hospital métodos de tratar doença vascular.
EP1499328B1 (en) 2002-04-15 2015-09-16 University of Pittsburgh - Of the Commonwealth System of Higher Education Methods of treating necrotizing enterocolitis
RS91004A (sr) 2002-04-15 2007-02-05 University Of Pittsburgh Of The Commonwealth System Of Higher Education, Postupci za lečenje ileusa
JP4549847B2 (ja) 2002-05-17 2010-09-22 イエール ユニバーシティ 肝炎の治療方法
DE10230165A1 (de) 2002-07-04 2004-01-15 Ino Therapeutics Gmbh Verfahren und Vorrichtung zur Administration von Kohlenmonoxid
US20040106954A1 (en) 2002-11-15 2004-06-03 Whitehurst Todd K. Treatment of congestive heart failure
JP5564158B2 (ja) 2003-07-09 2014-07-30 ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンテッド バイ ザ セクレタリー オブ ザ デパートメント オブ ヘルス アンド ヒューマン サービシーズ 亜硝酸塩によって特定の心臓血管状態を処置する方法
CN1898394B (zh) 2003-11-14 2012-05-30 科学工业研究委员会 检测高原肺水肿易感性的方法
CA2557814A1 (en) 2004-03-01 2005-09-15 Lumen Therapeutics, Llc Compositions and methods for treating diseases
JP2008519770A (ja) 2004-11-09 2008-06-12 シーブイ・セラピューティクス・インコーポレイテッド 心不全の処置における左室リモデリングを逆転させるための少なくとも1種のリモデリング物質と併用するラノラジンの使用
JP2008523090A (ja) 2004-12-08 2008-07-03 バイオマリン ファーマシューティカル インコーポレイテッド 新生児肺高血圧症の治療のための方法および組成物
US8551961B2 (en) 2005-05-25 2013-10-08 Massachusetts Institute Of Technology Localized delivery of cardiac inotropic agents
US7523752B2 (en) 2005-09-21 2009-04-28 Ino Therapeutics, Llc System and method of administering a pharmaceutical gas to a patient
WO2007067896A1 (en) 2005-12-05 2007-06-14 Ihc Intellectual Asset Management Llc Method for determining vasoreactivity
WO2007067570A1 (en) 2005-12-05 2007-06-14 Biomarin Pharmaceutical Inc. Methods and compositions for the treatment of disease
US8790715B2 (en) 2006-02-16 2014-07-29 Ino Therapeutics Llc Method and apparatus for generating nitric oxide for medical use
US20080193566A1 (en) 2007-02-09 2008-08-14 Miller Christopher C Use of high dose concentrations of gaseous nitric oxide
WO2009048521A1 (en) 2007-10-11 2009-04-16 Duke University Potentiating the effect of compound comprising nitric oxide
CA2702437C (en) 2007-11-28 2013-06-25 Teva Pharmaceutical Industries Ltd. Method of delaying the onset of clinically definite multiple sclerosis
KR20110053354A (ko) 2008-08-13 2011-05-20 노파르티스 아게 폐동맥 고혈압의 치료
AU2009202685B1 (en) 2009-06-30 2010-08-19 Ino Therapeutics Llc Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension

Similar Documents

Publication Publication Date Title
JP2011251155A5 (https=)
JP2011011059A5 (https=)
JP2020532531A5 (https=)
JP2012500004A5 (https=)
JP2013523349A5 (https=)
JP2012505014A5 (https=)
JP2014530874A5 (https=)
JP2011520917A5 (https=)
JP2014513722A5 (https=)
WO2013048153A3 (ko) 인간 b 세포에서 생산된 인플루엔자 a 바이러스 중화 활성을 가지는 결합 분자
JP2019206562A5 (https=)
JP2013510169A5 (https=)
JP2016014009A5 (https=)
Tian et al. Collagen Accumulation Does Not Impair Cardiopulmonary Recovery From Hypoxia, As Assessed Via Admittance Derived Pressure-Volume Loops In Mice
Aşkar et al. Management of Patients With Pulmonary Hypertension in COVID-19 Pandemic.
MD3552G2 (ro) Metodă de determinare a duratei maximal admisibile a efortului fizic
Hon et al. Assessment Of Acute Pulmonary Vascular Reactivity In Portopulmonary Hypertension
AU2015202618B2 (en) Methods of treating patients having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension
UA68460U (ru) Способ оценки эффективности лечения s-атенололом больных ишемической болезнью сердца со стенокардией и артериальной гипертензией с нарушением диастолической функции левого желудочка по "гипертрофическому" типу
Haque et al. Clinical Response of Enhanced External Counter Pulsation (EECP) Among Bangladeshi Ischemic Heart Disease Patients
Helgeson Pulmonary arterial hypertension: case report
Morecroft et al. Combined Serotonin Transporter and 5-HT1B Receptor Inhibitor LY393558 Reverses Established Pulmonary Hypertension (PAH) in Mice.
Gurovich et al. Myocardial Energetics Is Altered In Patients With Coronary Artery Disease: 2194Board# 73 June 3 2: 00 PM-3: 30 PM
Stack Interstitial lung disease: case report
UA68459U (ru) Способ оценки эффективности лечения s-метопрололом больных ишемической болезнью сердца со стенокардией и артериальной гипертензией с нарушением диастолической функции левого желудочка по "гипертрофическому" типу